VBWG
Monograph

Supplement to The American Journal of Cardiology October 18, 2001 vol. 88 (8A)

• A Symposium: Interventions in cardiology: Focus on lipid management in acute and long-term settings

Exciting new data have emerged on the relative roles of medical therapy and percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS). This supplement summarizes and discusses these new data and their implications, with a particular focus on the vascular biology of high-risk coronary lesions and the particular challenges of risk reduction in ACS. In this regard, the multifactorial nature of the underlying vascular biology of the unstable coronary plaque requires consideration of antiplatelet, antithrombin, and anti-ischemic therapies, as well as PCI.






8AACScoronaryExcitinginterventionsLipidPCIpercutaneousSupplementsyndromesVol

Related at vwbg.org

Vascular Biology in Clinical Practice © Vol. 4, No. 4

Anticoagulant therapy in the PCI patient

This monograph, Anticoagulant therapy in the PCI patient , is intended to explore the role of anticoagulant therapy in patients scheduled for percutaneous coronary intervention, particularly as it is evolving in regard to other components of antithrombotic therapy (i.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section IV: Antithrombotic interventions in acute coronary syndromes

The VBWG Core Curriculum 2003 slide lecture compendium Impact of vascular biology in treatment of cardiovascular disease , provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Core Curriculum

Impact of vascular biology in treatment of cardiovascular disease Section IV: Antithrombotic interventions in acute coronary syndromes

The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders.
More related